19 May 2013
Keywords: novartis, visudyne, use, extended, eu, ophthalmics, been
Article | 26 March 2001
Novartis Ophthalmics has been granted approval in the European Union tomarket Visudyne (verteporfin) for a new indication, the treatment of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 March 2001
28 March 2001
17 May 2013
© 2013 thepharmaletter.com